NEW YORK CITY -- A pregnant nurse was taking care of novel coronavirus patients in Brooklyn, until she got the virus herself. She then went on a ventilator and her heart stopped. Now, the woman who spent a career caring for patients is a patient who needs caring for full-time.Shirley Licin told our sister station…
As a physician's assistant, I've had my fair share of interesting days. I work at a hospital in the Chicago suburbs, where I've been a PA in the emergency department for three years. In the past month, I've worked with a handful of COVID-19 patients who have come to the ER. Physician's assistants are able to…
On April 5, Mary Agyeiwaa Agyapong, a pregnant 28-year-old nurse at England's Luton and Dunstable Hospital, tested positive for coronavirus. Two days later, she was admitted to the same hospital as her symptoms worsened.Concerned for the life of her unborn child, Agyapong consented to an emergency cesarean section. Her newborn daughter survived the procedure, but…
Image copyright Other Image caption Mary Agyeiwaa Agyapong tested positive for Covid-19 two days previously The baby of a "highly valued and loved" nurse has been delivered successfully after she died from Covid-19.Mary Agyeiwaa Agyapong, 28, had worked for five years at Luton and Dunstable University Hospital, where she died on Sunday. A hospital trust…
Published: October 30, 2026, 10:16 pm Several reports of children choking have led to an FDA warning against Once Upon A Time snacks. The warning covers all flavors, quantities, lots and dates of Once Upon A Farm Tractor Wheels Organic, Toddler Soft-Baked Bars. The FDA has received several reports that describe infants ages 1.5 to
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.